Interaction of apolipoprotein E ε 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease:: Problems pacing the investigator

被引:14
作者
Katzman, R
Kang, D
Thomas, R
机构
[1] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Alzheimer Dis Res Ctr, La Jolla, CA 92037 USA
关键词
Alzheimer-disease; genetic risk factors; apolipoprotein E; alleles; alpha-1-antichymotrypsin; VLDLR; multiple comparisons;
D O I
10.1023/A:1022461601609
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Apolipoprotein E4 allele (Apo-epsilon 4) is the major susceptibility gene for late onset Alzheimer Disease (AD) but epidemiological data suggest that the effect of this allele is modified in different individuals by genetic or environmental factors. Age and head injury are major non-genetic factors modifying the Apo-epsilon 4 risk. There is conflicting data as to whether alleles of other chaperon proteins (such as alpha-1-antichymotrypsin (ACT)) or Apo-epsilon 4 receptors (such as the VDRL receptor) modify the Apo-epsilon 4 risk for AD. We analyze problems posed by genetic association studies including those of multiple comparisons and selection of controls, the latter problem exacerbated by the wide variations in Apolipoprotein E allele frequencies observed in different groups and localities.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 81 条
[1]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[2]  
AUTILIO LA, 1963, J NEUROCHEM, V20, P733
[3]  
Bickeboller H, 1997, AM J HUM GENET, V60, P439
[4]   CONFIRMATION OF THE EPSILON-4 ALLELE OF THE APOLIPOPROTEIN-E GENE AS A RISK FACTOR FOR LATE-ONSET ALZHEIMERS-DISEASE [J].
BROUSSEAU, T ;
LEGRAIN, S ;
BERR, C ;
GOURLET, V ;
VIDAL, O ;
AMOUYEL, P .
NEUROLOGY, 1994, 44 (02) :342-344
[5]   UNDEREXPRESSION OF THE APOLIPOPROTEIN E2 AND E4 ALLELES IN THE GREEK CYPRIOT POPULATION OF CYPRUS [J].
CARIOLOU, MA ;
KOKKOFITOU, A ;
MANOLI, P ;
CHRISTOU, S ;
KARAGRIGORIOU, A ;
MIDDLETON, L .
GENETIC EPIDEMIOLOGY, 1995, 12 (05) :489-497
[6]   Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease [J].
Christie, RH ;
Chung, H ;
Rebeck, GW ;
Strickland, D ;
Hyman, BT .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (04) :491-498
[7]   Lack of association of trinucleotide repeat polymorphisms in the very-low-density lipoprotein receptor gene with Alzheimer's disease [J].
Chung, H ;
Roberts, CT ;
Greenberg, S ;
Rebeck, GW ;
Christie, R ;
Wallace, R ;
Jacob, HJ ;
Hyman, BT .
ANNALS OF NEUROLOGY, 1996, 39 (06) :800-803
[8]   POSTTRAUMATIC ALZHEIMERS-DISEASE - PREPONDERANCE OF A SINGLE PLAQUE TYPE [J].
CLINTON, J ;
AMBLER, MW ;
ROBERTS, GW .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1991, 17 (01) :69-74
[9]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[10]  
EGGERTSEN G, 1993, CLIN CHEM, V39, P2125